article Open Access
COVID-19 in tuberculosis in patients
International Journal of Advanced Research in Medicine · 2021 · Vol. 3(2) · pp. 432–434
Abstract
Coronavirus Disease 2019 (COVID‐19) has become a pandemic and the number of infected cases continues to rise. Millions have been laboratory‐confirmed cases and reported worldwide, with a mortality rate of 4.6%. To be the best of our knowledge, study not has yet evaluated the impact of tuberculosis on COVID‐19 severity and mortality in India. Therefore, we performed a study to assess whether biochemical values in tuberculosis is more deranged when compared to the person who is not having the tuberculosis and suffering from the infection of COVID‐19.
COVID-19 Clinical Research StudiesTuberculosis Research and EpidemiologyCOVID-19 diagnosis using AITuberculosisCoronavirus disease 2019 (COVID-19)PandemicMedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus2019-20 coronavirus outbreakMortality rateDiseaseVirology
Citations
0
FWCI
0.00
field-weighted impact
References
7
Percentile
19%
vs. same field & year
References
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
BMJ · 2009 · 82,871 citations
Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study
European Respiratory Journal · 2020 · 1,573 citations
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan
Journal of Allergy and Clinical Immunology · 2020 · 2,363 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.